Absorbed Dose Estimation
Absorbed Dose Estimation - Related Videos
10:33
Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification (ADCI) and Dose Estimation
0 Views •
Cited by 29 •
2017
The cytogenetic dicentric chromosome (DC) assay quantifies exposure to ionizing radiation. The Automated Dicentric Chromosome Identifier and Dose Estimator software accurately and rapidly estimates biological dose from DCs in metaphase cells. It distinguishes monocentric chromosomes and other objects from DCs, and estimates biological radiation dose from the frequency of DCs.
07:51
Gas Absorber
0 Views •
2023
Source: Michael G. Benton and Kerry M. Dooley, Department of Chemical Engineering, Louisiana State University, Baton Rouge, LA Gas absorbers are used to remove contaminants from gas streams. Multiple designs are used to accomplish this objective1. A packed bed column uses gas and liquid streams running counter to each other in a column packed with loose packing materials, such as ceramics, metals, and plastics, or structured packing1. The packed bed uses surface area created by the packing to...
13:44
Simulation, Fabrication and Characterization of THz Metamaterial Absorbers
0 Views •
Cited by 6 •
2012
This protocol outlines the simulation, fabrication and characterization of THz metamaterial absorbers. Such absorbers, when coupled with an appropriate sensor, have applications in THz imaging and spectroscopy.
01:28
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
0 Views •
2025
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
06:24
Minimal Erythema Dose (MED) Testing
0 Views •
Cited by 74 •
2013
This article describes how to conduct minimal erythema dose (MED) testing in order to determine the lowest dose of ultraviolet radiation that will cause erythema (burning) when administered to an individual.
FAQs
The main variables are administered activity, radiotracer distribution, physical decay, biological clearance, and energy deposition. Together, they determine how much radiation reaches a particular tissue and how long it remains there. Changing any of these factors can alter the estimated dose, even when two patients receive the same administered amount.
Physical decay describes the loss of radioactive activity over time, whereas biological clearance describes removal of the radiotracer from the body or from a specific region. Both processes reduce the activity available to deposit energy, but they represent different influences. Including both helps model how radiation accumulates over time rather than treating exposure as instantaneous.
Anatomical distribution links radiation exposure to specific tissues or organs instead of considering only the total amount administered. A radiotracer may produce different dose estimates in its target region and in healthy tissues, depending on where it concentrates. This regional perspective supports evaluation of tissue risks and helps distinguish treatment effects from unintended exposure.
Researchers can compare protocols by examining how administered activity, distribution, decay, clearance, and energy deposition translate into dose for selected anatomical regions. This provides more informative comparisons than activity alone, because protocols may expose target and healthy tissues differently. The resulting estimates can help evaluate radiopharmaceuticals and identify approaches that balance intended treatment with tissue protection.
A dose estimate requires information about the administered activity and how the radiotracer distributes through relevant tissues or organs. The calculation also accounts for physical decay, biological clearance, and energy deposited in the target. Combining these inputs produces a time-dependent picture of regional exposure that can support interpretation of medical radiation use.
It is especially valuable for radiation protection, treatment planning, and evaluation of radiopharmaceuticals. In treatment planning, regional estimates can support more personalized decisions by showing how exposure may differ among anatomical sites. In protection and protocol evaluation, they help clarify risks to healthy tissues and compare imaging or treatment approaches on a tissue-specific basis.